InnoServ taps new chief executive

Article

Independent service organization InnoServ Technologies of Corona,CA, has named Michael Puls as president and CEO. Puls fills aleadership role formerly held by Alan Margulis, who left the companyin March (SCAN 3/29/95). Puls moves to InnoServ from Senmed

Independent service organization InnoServ Technologies of Corona,CA, has named Michael Puls as president and CEO. Puls fills aleadership role formerly held by Alan Margulis, who left the companyin March (SCAN 3/29/95). Puls moves to InnoServ from Senmed MedicalVentures, which specializes in medical venture capital financing.

InnoServ reported second-quarter financial results (end-October)earlier this month. Revenues were $11.9 million with net incomeof $185,000, compared to sales of $13.4 million and a net lossof $528,000 in the same period last year.

For the first six months of the year, InnoServ posted revenuesof $23.9 million with net income of $71,000, compared to revenuesof $22.1 million and a net loss of $1.1 million in the same periodin 1994. InnoServ also announced that it had received a five-year$5.5 million contract for biomedical and clinical lab repair servicesat Children's Hospital in Columbus, OH.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.